IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
Sponsors and Collaborators
immatics Biotechnologies GmbH
Alexandra Kirner, PhD
+49 7071 5397400
Carsten Reinhardt, MD
+49 7071 5397100
Brian Rini, MD
Cleveland Clinic Taussig Cancer Institute
Tim Eisen, MD
Addenbrooke’s Hospital University of Cambridge, UK
Next post in Renal Cell Carcinoma Clinical Trials
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
Want to read more?
Please login or register first to view this content.